Wednesday, May 25, 2022 May 25, 2022
62° F Dallas, TX
Business

Dallas Healthcare Software Startup Bought by San Francisco’s Invitae Corp.

Public company Invitae Corp. has scooped up Dallas' Ommdom, which commercialized a healthcare software program called CancerGene Connect.
By  |
Image
Invitae Corp. has acquired the parent of Dallas software service CancerGene Connect, which initially developed at UT Southwestern.
Invitae Corp. has acquired the parent of Dallas software service CancerGene Connect, which initially developed at UT Southwestern.

A $10.3 million San Francisco genetic information public company, Invitae Corp., has acquired the parent of Dallas software service CancerGene Connect, which initially developed at UT Southwestern Medical Center.

Ommdom Inc., founded in 2015 to develop healthcare software including CancerGene Connect, sold all of its outstanding capital stock in exchange for about $6 million in Invitae common stock as part of the agreement. No other financial terms were disclosed.

CancerGene Connect, a 2015 graduate of the Tech Wildcatters accelerator in Dallas, was developed by former UT Southwestern breast surgical oncologist David Euhus. The software allows practitioners to input information about their patients’ family and personal histories of cancer to help run cancer risk assessment models. Clinicians use the information to provide actionable analysis and therapeutic decisions. Ommdom is led by CEO Richard Burghardt.

The acquisition helps Invitae expand its suite of genome management offerings to help patients and healthcare professionals use genetic information as part of the care plan. “Although most frequently discussed in relation to cancer, family health history also has significant and growing importance in the prevention and management of heart, metabolic, neurological, and other diseases,” Burghardt said in a release. “Joining Invitae will broaden the reach of our technology, bringing its benefits to more clinicians and their patients.”

CancerGene Connect dates back to the late 1990s at UT Southwestern. In 2013, the medical center won the Innovator Award from the Association of Community Cancer Centers for the software. Ommdom has an exclusive license from UT Southwestern to further develop and commercialize CancerGene Connect.

Related Articles

Research

UT Southwestern’s Dr. Todd Aguilera and Dr. Jeffrey Woodruff Win Big Funding Awards

Their research could be game changers for rectal cancer and infertility respectively.
By 
Research

UT Southwestern’s Dallas Heart and Mind Study Partners with Perspectum

The long-standing and ongoing study will use MRI technology to measure the impact of chronic liver disease.
Image
Coronavirus

UTSW Projections: Could There Be 2,500 New Daily COVID-19 Cases by January?

The latest modeling shows an alarming trend as hospital leaders warn, "this is getting serious."